Cardiovasc Diabetol June 2019 PMID 31234885

Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial.

Omar Sheikh, Anthony G Vande Hei, Ayman Battisha, Tarek Hammad, Son Pham, Robert Chilton

Download social card

Mentions

Peak: 4 in Jun 2019

across 2 sources since Jun 2019

Extended reach

60,994

potential audience

Total likes

1,886

Video views

57,609

Mentions per month

Jun 2019 – Jul 2024

Where it's discussed

X / Twitter6 posts
YouTube2 videos

AI synopsis

What people are saying

The collective discussions emphasize the importance of understanding the molecular mechanisms by which EPA affects heart health, with mentions of specific aspects like MOA and trial results, demonstrating both curiosity and support for the research findings. The tone is analytical and somewhat anticipatory about how this knowledge might influence treatment and supplement use.

AgreementModerate agreement

Most discussions align with the idea that omega-3 fatty acids, especially EPA, play a significant role in cardiovascular health and that understanding their mechanisms is important, supporting the article's focus.

InterestModerate interest

Participants show moderate interest by referencing mechanisms like MOA (mechanism of action) and specific trials, indicating they find the topic relevant but not exceedingly urgent or controversial.

EngagementModerate engagement

Posts include mentions of molecular mechanisms, trial data, and potential implications, reflecting a moderate level of in-depth discussion and curiosity about the research.

ImpactModerate impact

The discussions suggest an awareness of the research's relevance to clinical practice and supplement use, hinting at a moderate recognition of its broader significance.

Abstract in brief

The REDUCEIT trial showed that using icosapent ethyl (a purified form of EPA) significantly reduced the risk of major cardiovascular events such as death, heart attack, and stroke, but it also increased the risk of atrial fibrillation and bleeding.
The text discusses the importance of understanding how omega-3 fatty acids, particularly EPA, work at the molecular level to influence heart health beyond just lowering triglyceride levels.
The goal is to explore the mechanisms by which EPA affects cardiovascular and blood-related processes to better explain their benefits and risks in treating heart disease.

Read the full abstract

All mentions

Supplements for Heart Attack and Stroke Prevention Explained

This video examines evidence from meta-analysis studies on folic acid and B vitamins' role in reducing stroke and cardiovascular risks, highlighting their potential benefits for heart health and disease prevention.

Dr. Jin W. Sung · Apr 26, 2022 43,140 views

Impact of Avocado Consumption on Cardiovascular Disease Risk

This video explores the link between avocado consumption and cardiovascular health. A 30-year study revealed that two or more servings of avocado per week can reduce the risk of cardiovascular disease by 16%. Learn…

Dr. Jin W. Sung · Apr 30, 2024 14,469 views

nickolaos

@nickolaos16 · X

2 Supplements for HEART ATTACK

Jul 4, 2024 · 16 followers View post →

Jerry Dean Bowers

@vipertoxin · X

(285) 2 Supplements for HEART ATTACK

Apr 27, 2022 · 554 followers View post →

drgurkankaraca

@karacagurkan · X

Jun 28, 2019 · 651 followers View post →

Joey Sales

@sales_js · X

RT @JohnCappello: MOA of icosapent ethyl, discussed $AMRN https://t.co/W2RSD1pVmd

Jun 27, 2019 · 2 shares · 1,055 followers View post →

MaximizeBelief

@MaximizeBelief2 · X

RT @JohnCappello: MOA of icosapent ethyl, discussed $AMRN https://t.co/W2RSD1pVmd

Jun 27, 2019 · 2 shares · 244 followers View post →

JohnCappello

@JohnCappello · X

MOA of icosapent ethyl, discussed $AMRN https://t.co/W2RSD1pVmd

Jun 27, 2019 · 8 likes · 2 shares · 853 followers View post →